Oral fexinidazole dosing regimens for the treatment of adults with chronic indeterminate Chagas disease

Foto: DNDi
04/10/2017 - 31/12/2018
Joaquim Gascon

Phase 2 Randomized, Multicenter, Double-blinded Safety and Efficacy Study

The general objective of this clinical trial is to determine the efficacy and safety of alternative dosing regimens of FEXI in reducing and clearing T. cruzi parasitemia in adult individuals with the chronic indeterminate Chagas Disease, in comparison to historical placebo control.

This is  a double-blind, randomized, prospective, comparative, pharmacokineticpharmacodynamic, and proof-of-concept trial design, with three-parallel groups and historical placebo control. The trial will be conducted in 5 different sites in Spain. The trial will be sufficiently powered to compare the efficacy and safety of each of the dosing regimens of FEXI with historical placebo control. Efficacy and safety will be monitored by an external independent Data Monitoring Committee (DMC) on an ongoing basis. The committee is to include cardiac and liver safety experts, as well as Chagas Disease clinical expertise.

The total duration of patient trial participation will be approximately 14 months.

Our Team


  • Joaquim Gascon
    Joaquim Gascon Research Professor, Director de la Iniciativa de Chagas i del Programa de Chagas i malalties parasitàries i importades

ISGlobal team

Veure més

Altres projectes

Veure projectes passats


Noves Eines per al Diagnòstic i l'Avaluació del Pacient amb Malaltia de Chagas

Control of Leishmaniasis. From bench to bedside and community


Grup de recerca en patología importada i malaties emergents i re-emergents


Biomarcadores inmunológicos antígeno-específicos (células T) asociados al control de la infección por T. cruzi


Modelo y Herramienta para la construcción de estrategias para el incremento de la atención en Chagas


Towards the interruption of transmission of soil-transmitted helminths


Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas


Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.